Catherine Skari

Delegation Visit to Austria – 11-13 April 2019

TIF’s Board of Directors Member and Expert Patient, Mr. George Constantinou, and TIF’s collaborators Dr. Eva-Maria Knoll and Dr. Anne…

Read More »

Living with Transfusion-Dependent β-Thalassaemia (TDT)

In its most severe form and without adequate care, thalassaemia can be lethal in early childhood, and although  International Thalassaemia…

Read More »

Delegation Visit to Vietnam – 24 & 25 April 2019

Read More »

International Thalassaemia Day: More than 1 in 10 Cypriots carriers of β-thalassaemia

  A comprehensive article by Carsten W. Lederer (PhD), Petros Patsali (PhD), Panayiota Papasavva (MD, MSc), Thessalia Papasavva (PhD) and…

Read More »

Corporate Reputation of Pharma Companies for 2018 – The Patients’ Perspective

What did 1,500 patient groups from different countries and therapy areas think of pharmaceutical companies in 2018? To what extent…

Read More »

Gene Therapy for β-Thalassaemia Approaches European Market Approval

Gene therapy continues to evolve with new emerging treatments finally reaching its promised potential: providing a one-time lifelong cure for…

Read More »

World Hemophilia Day 2019

World Hemophilia Day is an international awareness day for hemophilia and other bleeding disorders. It is held annually on April…

Read More »

TIF held its 1st Board of Directors Meeting for 2019 in Fujairah, UAE

Read More »

TIF Signs Agreement With Resonance Health To Deploy FerriSmart®

FerriSmart is an AI-driven system for automated real-time measurement of liver-iron concentrate (LIC) in patients, using non-invasive MRI-based technology. Under…

Read More »

La Repubblica: Gene Editing Cured Two Siblings With Thalassaemia In Italy

Cured of thalassemia, thanks to gene editing. According to a recent news report published in the Italian newspaper La Repubblica,…

Read More »